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S U M M A R Y
Two cases of neonatal group B streptococcal (GBS) infection occurring in a large consanguineous kindred
are described. The observation suggests that susceptibility to isolated GBS disease in this family may
have been the result of an inborn error of immunity inherited as a Mendelian autosomal recessive trait.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Group B Streptococcus (GBS) is a common colonizer of the
human gastrointestinal and genitourinary tracts causing disease
primarily in pregnant/post-partum women and infants younger
than 3 months of age.1 The estimated global incidence of neonatal
GBS disease (deﬁned as GBS infection occurring at 0–89 days of
life) is 0.53 per 1000 live births (see additional references in the
Supplementary Material).
Neonatal GBS disease is commonly considered an environmental
condition, linked to the virulence of the microorganism or to
‘neonatal immunodeﬁciency’. However, after the acquisition of GBS
from the maternal genital tract, breast milk, or the environment,
most infants are colonized by GBS without developing an overt
infection, and only a small proportion of exposed infants develop* Corresponding author. Tel.: +41 21 693 71 48.
E-mail address: alessandro.borghesi@epﬂ.ch (A. Borghesi).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).early-onset disease (EOD; onset at 6 days of life) or late-onset
disease (LOD; onset at >6 days of life). Only 1–2% of infants
colonized at birth develop EOD (10–30% of all pregnant women are
colonized with GBS, and approximately 50% of infants born to
colonized mothers are in turn colonized with GBS).1 The proportion
of colonized infants that develop LOD is probably lower, given the
decreasing incidence with age and a likely increasing cumulative
exposure/colonization rate with increasing age.
Known risk factors (reported in the Supplementary Material)
identify groups of infants at risk of invasive infection,1 but are
unable to predict the occurrence of GBS disease at the individual
level. Furthermore, a signiﬁcant proportion of GBS infection occurs
in otherwise healthy full-term infants in the absence of established
risk factors,2 suggesting a role for additional, as-yet unidentiﬁed
individual mechanisms of susceptibility.
Anecdotal reports in the literature describe the occurrence of
GBS disease in association with primary or acquired immunode-
ﬁciencies (reviewed in the Supplementary Material). Invasive GBS
infection has also been reported in infants with interleukinociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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tion primary response 88 (MyD88) deﬁciency,3,4 two conditions
causing vulnerability to a broad range of pyogenic bacteria,
suggesting that toll-like receptor/interleukin 1 receptor signalling
is essential for the protective responses to GBS. However, GBS
infection is a rare manifestation of IRAK-4/MyD88 deﬁciency and
almost always occurs as a sporadic and isolated infection. Thus,
there is so far no clear evidence for a host genetic contribution to
susceptibility to isolated GBS disease.
This is the ﬁrst description of two cases of isolated neonatal GBS
disease occurring in two infants in two related families in a large
consanguineous kindred of the Sinti ethnic group. The report
provides the ﬁrst clue of a possible genetic origin of isolated GBS
disease.
2. Case reports
The pedigree of the large consanguineous kindred is shown in
Figure 1. No known immunological diseases, immunodeﬁciencies,
or autoimmune diseases were reported in the family. No life-
threatening infections, including GBS disease, were reported other
than those occurring in case 1 (V.4) and case 2 (V.5). The 3-year-old
sister of case 1 and the three sisters of case 2 are healthy.
Case 1 was a 48-day-old boy admitted to the paediatric unit of
the hospital because of clinical signs of sepsis. Two blood cultures
were positive for GBS. The infant was initially treated with a 26-
day antibiotic course and with subsequent additional antibiotic
courses due to relapsing fever, increases in inﬂammatory markers,
seizures, and the discovery of an intracranial subdural empyema
(Supplementary Material, Figure S1). The clinical course was
eventually favourable. Antibiotics were stopped and the infant was
discharged home. He is currently aged 1 year and 3 months and is
free of infection. A detailed history of the clinical course and the
laboratory tests performed during his hospital stay are reported in
the Supplementary Material (Table S1). The baseline immuno-
logical evaluation including lymphocyte subpopulation numbers,Figure 1. The large consanguineous kindred. The parents of case 1 (V.4) are second-degr
consanguinity is expected, since inbreeding is common in Sinti communities.immunophenotype, and serum immunoglobulins was normal for
the patient’s age (Supplementary Material, Table S2). A ﬂow
cytometry-based evaluation of the cleavage of membrane-bound
L-selectin (CD62L) on granulocytes upon activation with lipopoly-
saccharide, to assess the integrity of the signalling from the toll-
like receptors, was performed.5 Despite a low baseline expression
of CD62L in the patient, a shedding response could be observed,
thus excluding a complete IRAK-4 or MyD88 deﬁciency (Supple-
mentary Material, Figure S2).
Case 2 was a girl born at another hospital to a 32-year-old
primigravida by spontaneous delivery at 35 weeks of gestation.
The birth weight was 2170 g. The maternal vaginal–rectal swab
was not performed because of the premature delivery. The infant
was immediately transferred to the neonatal intensive care unit
due to her poor clinical condition. Despite antibiotics, mechanical
ventilation, and cardio-circulatory support, the infant died at 48 h
of life. GBS was isolated from blood culture.
3. Discussion
To our knowledge, this is the ﬁrst report of familial recurrence
of isolated GBS infection in a large consanguineous kindred.
Each of the two reported cases, taken separately, clinically
overlaps with previous reports of sporadic GBS disease in its
classical early-onset (case 2) and late-onset (case 1) presentations.
Case 1 was a healthy full-term infant who was discharged home
and who developed GBS disease in the absence of any known risk
factor. Similar cases are commonly seen among patients admitted
to neonatal intensive care or paediatric units. The limited
information available for case 2 suggests a typical presentation
of fulminant early-onset GBS disease, which can occur with or
without established risk factors.
Despite the classical presentations, the cases drew attention
because of the familial recurrence in the presence of consanguinity,
suggesting a shared common determinant of susceptibility byee cousins. The parents of case 2 (V.5) are second-degree cousins. A high degree of
F. Licciardi et al. / International Journal of Infectious Diseases 51 (2016) 22–2424affected but not unaffected individuals, both exposed to the same
environment.
Complete IRAK-4 and MyD88 deﬁciencies were excluded by a
simple ﬂow cytometry assay (Supplementary Material,
Figure S2).5 Indeed, despite low baseline CD62L expression on
the neutrophil surface, the shedding of CD62L could still be
observed after stimulation with lipopolysaccharide.
Low maternal serum anti-capsular GBS antibodies have been
associated with an increased risk of GBS disease early in life. Serum
maternal anti-GBS antibody levels were not measured; thus, it
cannot be excluded that ﬂuctuations in their concentrations may
explain the susceptibility in cases 1 and 2 and resistance in their
non-affected siblings. However, the consanguinity of the family
makes more likely the hypothesis that the determinant of
susceptibility is a Mendelian defect inherited with an autosomal
recessive pattern, underlying a rare inborn error of immunity
affecting the protective primary innate immune response to GBS.
GBS disease occurred in the absence of known risk factors in case 1,
supporting the idea that traditional risk factors for GBS disease are
not causative, but rather identify groups of infants that are more
likely to carry as-yet unidentiﬁed determinants of susceptibility.
The present report also raises the question of whether EOD and
LOD, different in terms of source of infection, route of transmission,
risk factors, age at onset, clinical manifestations, and prevention
possibilities, are two sides of the same coin; i.e., they are
epidemiologically distinct conditions sharing the same molecular
disease pathways.
It is important to anticipate here that any disease-causing allele
identiﬁed in this family would be exceedingly rare in the general
population, given its potential lethality early in life following
natural exposure to GBS, a ubiquitous pathogen. Genetic defects
will probably account for a minority of cases of sporadic GBSdisease. Other non-genetic molecular mechanisms will probably
explain the susceptibility to GBS disease in the majority of
individuals. A comprehensive understanding of all of the mecha-
nisms underlying this enigmatic disease is required to develop
cost-effective preventive strategies for those at the most vulnera-
ble ages.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ijid.2016.08.010.
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